MaaT Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2017
Period Ending	Sep '24 Sep 25, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2017
Market Capitalization	104	81	79	132	-	-	Upgrade
Market Cap Growth	18.94%	2.32%	-40.01%	-	-	-	Upgrade
Enterprise Value	90	59	49	123	-	-	Upgrade
Last Close Price	7.46	6.98	8.00	13.35	-	-	Upgrade
PE Ratio	-	-4.02	-5.76	-3.59	-	-	Upgrade
PS Ratio	34.52	36.35	55.35	135.75	-	-	Upgrade
PB Ratio	4.05	3.96	2.95	3.31	-	-	Upgrade
P/FCF Ratio	-	-4.10	-5.97	-16.16	-	-	Upgrade
P/OCF Ratio	-	-4.34	-6.28	-16.64	-	-	Upgrade
EV/Sales Ratio	34.95	26.41	34.22	126.09	-	-	Upgrade
EV/EBITDA Ratio	-3.73	-2.98	-3.68	-14.07	-	-	Upgrade
EV/EBIT Ratio	-3.69	-2.95	-3.61	-13.78	-	-	Upgrade
EV/FCF Ratio	-4.74	-2.98	-3.69	-15.01	-	-	Upgrade
Debt / Equity Ratio	-	0.69	0.42	0.15	0.38	-1.82	Upgrade
Debt / FCF Ratio	-	-0.71	-0.86	-0.71	-0.99	-	Upgrade
Asset Turnover	-	0.05	0.03	0.03	-	0.01	Upgrade
Inventory Turnover	-	7.41	16.05	-	-	-	Upgrade
Quick Ratio	-	2.65	4.38	9.93	7.75	0.70	Upgrade
Current Ratio	-	2.78	4.57	10.05	7.76	0.71	Upgrade
Return on Equity (ROE)	-	-83.41%	-41.14%	-32.33%	-92.67%	-	Upgrade
Return on Assets (ROA)	-	-28.44%	-18.00%	-15.08%	-20.62%	-57.38%	Upgrade
Return on Capital (ROIC)	-	-34.28%	-20.21%	-16.43%	-25.55%	-102.13%	Upgrade
Earnings Yield	-27.20%	-24.34%	-17.32%	-6.84%	-	-	Upgrade
FCF Yield	-18.24%	-24.40%	-16.76%	-6.19%	-	-	Upgrade
Buyback Yield / Dilution	-14.89%	-307.65%	-135.06%	-	-	Upgrade
Total Shareholder Return	-14.89%	-307.65%	-135.06%	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.